Angel L Guerrero-Zotano (Angel Guerrero-Zotano, Ángel Guerrero-Zotano)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Cell Proliferation

Gene Expression

Metastatic Breast Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Angel L Guerrero-Zotano, Stefania Belli, Christoph C Zielinski, Juan Miguel Gil-Gil, Antonio Fernandez-Serra, Manuel Ruiz Borrego, Eva Ciruelos Gil, Javier Pascual, Montserrat Muñoz, Begoña Bermejo, Mireia Margelí, Antonio Antón-Torres, Laura Murillo, Bella Nisenbaum, Yuan Liu, Jesus Herranz, Daniel Fernandez-Garcia, Rosalía Caballero, Jose Antonio Lopez-Guerrero, Roberto Bianco, Luigi Formisano, Nicholas C Turner, Miguel Martin
CCNE1 and PLK1 mediates resistance to palbociclib in HR+/HER2- metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karama Asleh, Ana Lluch, Angela Goytain, Carlos Henrique Barrios, Xue Qi Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz Borrego, Samuel C Y Leung, Jose Bines, Angel L Guerrero-Zotano, José Angel García-Saenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres, Juan R De la Haba-Rodríguez, Francisco Ayala, Henry L Gómez, Federico Rojo, Torsten O Nielsen, Miguel Martin
Triple negative PAM50 non-basal breast cancer subtype predicts benefit from extended adjuvant capecitabine. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum, Debora Fumagalli, Christos Sotiriou, Einav Nili Gal-Yam, Mark E Robson, Justin Ndozeng, Andrea Gombos, Eva Ciruelos Gil, Evandro de Azambuja, Giuseppe Viale, Elsemieke D Scheepers, Curigliano Giuseppe, Judith M Bliss, Jorge S Reis-Filho, Marco Colleoni, Marija Balić, Fatima Cardoso, Joan Albanell, Caroline Duhem, Sandrine Marreaud, Dario Romagnoli, Beatriz Rojas, Andrea Gombos, Hans P M W Wildiers, Angel L Guerrero-Zotano, Peter S Hall, Andrea Bonetti, Karolina Fs Larsson, Martina Degiorgis, Silvia Khodaverdi, Richard Greil, Ásgerdur Sverrisdóttir, Marta Paoli, Ethel Seyll, Sibylle Loibl, Barbro Linderholm, Gabriele Zoppoli, Nancy E Davidson, Oskar Th Johannsson, Philippe L Bedard, Sherene Loi, Susan Knox, David A Cameron, Nadia Harbeck, Maite Lasa Montoya, Mariana Brandão, Andrea Vingiani, Carmela Caballero, Florentine S Hilbers, Lucy R Yates, Matteo Benelli, David Venet, Martine J Piccart
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative. Cancer discovery 11 (11) (2021)
Alberto Servetto, Rahul Kollipara, Luigi Formisano, Chang-Ching Lin, Kyung-Min Lee, Dhivya R Sudhan, Paula I Gonzalez Ericsson, Sumanta Chatterjee, Angel L Guerrero-Zotano, Saurabh Mendiratta, Hiroaki Akamatsu, Nicholas James, Roberto Bianco, Ariella B Hanker, Ralf Kittler, Carlos L Arteaga
Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Kyung-Min Lee, Angel L Guerrero-Zotano, Alberto Servetto, Dhivya R Sudhan, Chang-Ching Lin, Luigi Formisano, Valerie M Jansen, Paula I Gonzalez Ericsson, Melinda E Sanders, Thomas P Stricker, Ganesh Raj, Kevin M Dean, Reto Paul Fiolka, Lewis C Cantley, Ariella B Hanker, Carlos L Arteaga
Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer. Nature communications 11 (1) (2020)
Luigi Formisano, Yao Lu, Alberto Servetto, Ariella B Hanker, Valerie M Jansen, Joshua A Bauer, Dhivya R Sudhan, Angel L Guerrero-Zotano, Sarah Croessmann, Yan Guo, Paula I Gonzalez Ericsson, Kyung-Min Lee, Mellissa J Nixon, Luis J Schwarz, Melinda E Sanders, Teresa C Dugger, Marcelo Rocha Cruz, Amir Behdad, Massimo Cristofanilli, Aditya Bardia, Joyce O'Shaughnessy, Rebecca J Nagy, Richard B Lanman, Nadia Solovieff, Wei He, Michelle Miller, Fei Su, Yu Shyr, Ingrid A Mayer, Justin M Balko, Carlos L Arteaga
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. Nature communications 10 (1) (2019)
Dhivya R Sudhan, Luis J Schwarz, Angel L Guerrero-Zotano, Luigi Formisano, Mellissa J Nixon, Sarah Croessmann, Paula I Gonzalez Ericsson, Melinda Sanders, Justin M Balko, Francesca Avogadri-Connors, Richard E Cutler, Alshad S Lalani, Richard Bryce, Alan Auerbach, Carlos L Arteaga
Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER+/HER2+ Breast Cancers: Implications to the ExteNET Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (2) (2018)